ArticlePharmaceutics2022

Non-Invasive Physical Plasma for Preventing Radiation Dermatitis in Breast Cancer: A First-In-Human Feasibility Study.

Cas Stefaan Dejonckheere et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.